The UK’s first fully-licensed EU-GMP medical cannabis cultivation facility launched its product earlier this month.
UK brand, HEMPE, has secured NSF certification for its CBD gel, giving it the green-light for use among professional athletes and military personnel. The Dorset-based brand...
The UK Government is being sued by a CBD business for £3.4m, in the latest major challenge to its mishandling of legal hemp. Ocean Development (Dorset)...
Jazz Pharmaceuticals has shared new data on Epidiolex in patients with tuberous sclerosis complex (TSC).
The Food Standards Agency (FSA) is set to launch an eight-week public consultation period early next year.
Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch...
Via Business of Cannabis Mere hours after the results of the US election became clear, sending North American cannabis stocks into free fall, Germany’s ruling traffic...
It is the first comprehensive review of evidence on medical cannabis and epilepsy for clinicians, patients, and regulators.
The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021.
The French ANSM assured at the beginning of the year that cannabis-based treatments would be available by 2025.
